Key Statistics for 4517
|Current P/E Ratio (ttm)
Relative P/E vs.
|Earnings Per Share (ttm)
|Est. PEG Ratio
|Market Cap (M JPY)
|Shares Outstanding (M)
|30 Day Average Volume
|Dividend Indicated Gross Yield
|Cash Dividend (JPY)
|5 Year Dividend Growth
|Next Earnings Announcement
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for 4517
- Net Income (M/JPY)
BIOFERMIN PHARMACEUTICAL CO., LTD. manufactures pharmaceutical products and markets them through Takeda Chemical Industries in Japan and overseas markets. The Company sells its brand products, Biofermin, which is lactate gastrointestinal reagents. Biofermin also produces food stuffs, food additives, feed stuffs, and agrochemicals including fertilizer.
More Company Profile & Key Executives for 4517
|Takahito OhnishiChairman||Takaaki FujimotoPresident|
|Hideyuki WakeExecutive Vice President||Hideki YamamuraDirector|
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries